Literature DB >> 12181331

Downstream E-box-mediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: evidence for an endogenous mechanism of transcriptional repression.

Izumi Horikawa1, P LouAnn Cable, Sharlyn J Mazur, Ettore Appella, Cynthia A Afshari, J Carl Barrett.   

Abstract

Regulation of the hTERT gene encoding the telomerase catalytic subunit plays an important role in human cell senescence, immortalization, and carcinogenesis. By examining the activity of various deleted or mutated hTERT promoter fragments, we show that an E-box element downstream of the transcription initiation site is critical to differential hTERT transcription between the telomerase/hTERT-positive renal cell carcinoma cell line (RCC23) and its telomerase/hTERT-negative counterpart containing a transferred, normal chromosome 3 (RCC23+3). This E-box element mediated repression of hTERT transcription in RCC23+3 but not in RCC23. A copy number-dependent enhancement of the repression suggested active repression, rather than loss of activation, in RCC23+3. Endogenous expression levels of c-Myc or Mad1, which could activate or repress hTERT transcription when overexpressed, did not account for the differential hTERT transcription. Gel mobility shift assays identified the upstream stimulatory factors (USFs) as a major E-box-binding protein complex in both RCC23 and RCC23+3 and, importantly, detected an RCC23+3-specific, E-box-binding factor that was distinct from the USF and Myc/Mad families. The E-box-mediated repression was also active in normal human fibroblasts and epithelial cells and inactive in some, but not all, telomerase/hTERT-positive cancer cells. These findings provide evidence for an endogenous, repressive mechanism that actively functions in telomerase/hTERT-negative normal cells and becomes defective during carcinogenic processes, e.g., by an inactivation of the telomerase repressor gene on chromosome 3.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12181331      PMCID: PMC117927          DOI: 10.1091/mbc.e01-11-0107

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  51 in total

Review 1.  Emerging connections between DNA methylation and histone acetylation.

Authors:  J R Dobosy; E U Selker
Journal:  Cell Mol Life Sci       Date:  2001-05       Impact factor: 9.261

2.  TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin.

Authors:  A van Bokhoven; M Varella-Garcia; C Korch; G J Miller
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

3.  Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.

Authors:  A L Ducrest; M Amacker; Y D Mathieu; A P Cuthbert; D A Trott; R F Newbold; M Nabholz; J Lingner
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

Review 4.  Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT).

Authors:  J C Poole; L G Andrews; T O Tollefsbol
Journal:  Gene       Date:  2001-05-16       Impact factor: 3.688

5.  Mechanism for the reduction of telomerase expression during muscle cell differentiation.

Authors:  K Nozawa; K Maehara; K Isobe
Journal:  J Biol Chem       Date:  2001-03-28       Impact factor: 5.157

6.  Inhibition of telomerase limits the growth of human cancer cells.

Authors:  W C Hahn; S A Stewart; M W Brooks; S G York; E Eaton; A Kurachi; R L Beijersbergen; J H Knoll; M Meyerson; R A Weinberg
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

7.  c-Myc-mediated regulation of telomerase activity is disabled in immortalized cells.

Authors:  R Drissi; F Zindy; M F Roussel; J L Cleveland
Journal:  J Biol Chem       Date:  2001-06-11       Impact factor: 5.157

8.  The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.

Authors:  A S Majumdar; D E Hughes; S P Lichtsteiner; Z Wang; J S Lebkowski; A P Vasserot
Journal:  Gene Ther       Date:  2001-04       Impact factor: 5.250

9.  Upregulation of the gene encoding a cytoplasmic dynein intermediate chain in senescent human cells.

Authors:  I Horikawa; E S Parker; G G Solomon; J C Barrett
Journal:  J Cell Biochem       Date:  2001       Impact factor: 4.429

10.  Rearrangements of minisatellites in the human telomerase reverse transcriptase gene are not correlated with its expression in colon carcinomas.

Authors:  H Szutorisz; R Palmqvist; G Roos; R Stenling; D F Schorderet; R Reddel; J Lingner; M Nabholz
Journal:  Oncogene       Date:  2001-05-03       Impact factor: 9.867

View more
  35 in total

1.  Potent antitumoral efficacy of a novel replicative adenovirus CNHK300 targeting telomerase-positive cancer cells.

Authors:  C-Q Su; J Sham; H-B Xue; X-H Wang; D Chua; Z-F Cui; L-H Peng; L-F Li; L-H Jiang; M-C Wu; Q-J Qian
Journal:  J Cancer Res Clin Oncol       Date:  2004-07-09       Impact factor: 4.553

2.  Differential cis-regulation of human versus mouse TERT gene expression in vivo: identification of a human-specific repressive element.

Authors:  Izumi Horikawa; Y Jeffrey Chiang; Tricia Patterson; Lionel Feigenbaum; Sun-Hee Leem; Eriko Michishita; Vladimir Larionov; Richard J Hodes; J Carl Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

Review 3.  Regulation of the human catalytic subunit of telomerase (hTERT).

Authors:  Michael Daniel; Gregory W Peek; Trygve O Tollefsbol
Journal:  Gene       Date:  2012-02-13       Impact factor: 3.688

4.  Human Telomerase Reverse Transcriptase (hTERT) Transcription Requires Sp1/Sp3 Binding to the Promoter and a Permissive Chromatin Environment.

Authors:  De Cheng; Yuanjun Zhao; Shuwen Wang; Wenwen Jia; Jiuhong Kang; Jiyue Zhu
Journal:  J Biol Chem       Date:  2015-10-20       Impact factor: 5.157

5.  A Combinatory Strategy for Detection of Live CTCs Using Microfiltration and a New Telomerase-Selective Adenovirus.

Authors:  Yanchun Ma; Sijie Hao; Shuwen Wang; Yuanjun Zhao; Bora Lim; Ming Lei; David J Spector; Wafik S El-Deiry; Si-Yang Zheng; Jiyue Zhu
Journal:  Mol Cancer Ther       Date:  2015-01-14       Impact factor: 6.261

6.  HIF-1alpha induces cell cycle arrest by functionally counteracting Myc.

Authors:  Minori Koshiji; Yukio Kageyama; Erin A Pete; Izumi Horikawa; J Carl Barrett; L Eric Huang
Journal:  EMBO J       Date:  2004-04-08       Impact factor: 11.598

7.  Short rare hTERT-VNTR2-2nd alleles are associated with prostate cancer susceptibility and influence gene expression.

Authors:  Se-Lyun Yoon; Se-Il Jung; Eun-Ju Do; Se-Ra Lee; Sang-Yeop Lee; In-Sun Chu; Wun-Jae Kim; Jaeil Jung; Choung Soo Kim; Sang-Hyeon Cheon; Sun-Hee Leem
Journal:  BMC Cancer       Date:  2010-07-26       Impact factor: 4.430

8.  Localization of an hTERT repressor region on human chromosome 3p21.3 using chromosome engineering.

Authors:  Satoshi Abe; Hiromi Tanaka; Tomomi Notsu; Shin-Ichi Horike; Chikako Fujisaki; Dong-Lai Qi; Takahito Ohhira; David Gilley; Mitsuo Oshimura; Hiroyuki Kugoh
Journal:  Genome Integr       Date:  2010-05-26

9.  Differential repression of human and mouse TERT genes during cell differentiation.

Authors:  Shuwen Wang; Yuanjun Zhao; Chunguang Hu; Jiyue Zhu
Journal:  Nucleic Acids Res       Date:  2009-03-06       Impact factor: 16.971

10.  Interferon-inducible IFI16, a negative regulator of cell growth, down-regulates expression of human telomerase reverse transcriptase (hTERT) gene.

Authors:  Lynda Li Song; Larissa Ponomareva; Hui Shen; Xin Duan; Fatouma Alimirah; Divaker Choubey
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.